The Management and Board of Directors of Cypress Bioscience Inc. are committed to operating the company in an efficient, compliant and ethical manner, thereby improving our ability to grow and create value for our stockholders. Below is a copy of our Code of Conduct, Corporate Governance Guidelines, Comprehensive Compliance Program and Stockholder Communications Policy.

To achieve these principles, Cypress' Board of Directors maintains three operating committees: the Audit Committee, the Compensation Committee, the Strategy Commitee and the Nominating Committee. Each committee has its own written charter provided below. In addition, we have listed the members of each Board Committee.